{"id":387031,"date":"2015-04-20T00:00:00","date_gmt":"2015-04-20T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/rpeu11cx15-medtech-clot-management-devices-europe-2015-market-analysis\/"},"modified":"2026-04-15T07:31:41","modified_gmt":"2026-04-15T07:31:41","slug":"rpeu11cx15-medtech-clot-management-devices-europe-2015-market-analysis","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/rpeu11cx15-medtech-clot-management-devices-europe-2015-market-analysis\/","title":{"rendered":"Clot Management Devices | Europe | 2015 | Market Analysis"},"content":{"rendered":"<p>The European market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatment of\u00a0AV\u00a0access thrombosis,\u00a0PAD,\u00a0VTE,\u00a0CAD, and\u00a0AIS.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for clot management devices in Europe across a 10-year period.<\/p>\n<div class=\"clr\" style=\"zoom: 1; line-height: 16.9px; clear: both; height: 1px; overflow: hidden; margin: -1px 0px 0px; color: rgb(51, 51, 51); font-family: Arial, \"Times New Roman\", Times, serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;\">\u00a0<\/div>\n","protected":false},"template":"","class_list":["post-387031","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-geography-europe","medtech-date-731"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/387031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":3,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/387031\/revisions"}],"predecessor-version":[{"id":575157,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/387031\/revisions\/575157"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=387031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}